Treatment Response Adapted Hybrid Radiotherapy in Metastatic Non-small Cell Lung Cancer Receiving First-line Immunotherapy
Clinical trial NCT06313541 · UNKNOWN
Trial details
- NCT number
- NCT06313541
- Sponsor
- Fudan University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-10
- Primary completion
- 2025-06-30
- Enrollment
- 146
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.